John Harold Leaman
CIK 1586657 · Chief Fin. & Business Officer · last filed 2026-07-14
John Harold Leaman is a Chief Fin. & Business Officer who has filed 15 SEC Form 4 insider transactions across 4 companies since 2013. The most recent filing, for TRAW, was dated Jul 14, 2026. Current disclosed insider exposure totals $2.1K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$2.1K
4
15
$0
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| TRAW | Director | 4,058 | $0.51 | $2.1K | $0 | 5 | 2026-07-14 |
| IPI Legacy Liquidation Co (IMPL) Delisted | Chief Fin. & Business Officer | 10,571 | $0.24 | $2.5K | $0 | 5 | 2023-02-16 |
| Cartesian Therapeutics, Inc. (SELB) Delisted | CFO, Treas. & Hd Corp Strategy | — | $0.88 | — | $0 | 2 | 2018-06-19 |
| Aevi Genomic Medicine, LLC (MDGN.WS) Delisted | Chief Financial Officer | — | — | — | $0 | 2 | 2015-02-20 |
Recent Filings
15 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-07-14 | TRAW | Grant (A) | — | $0 | EDGAR |
| 2026-03-10 | TRAW | Grant (A) | — | $0 | EDGAR |
| 2025-12-16 | TRAW | Grant (A) | +4,058 | $0 | EDGAR |
| 2025-11-25 | TRAW | Grant (A) | — | $0 | EDGAR |
| 2025-10-14 | TRAW | Grant (A) | — | $0 | EDGAR |
| 2023-05-12 | — | Notice (144) | −6,944 | -$16.0K | EDGAR |
| 2023-02-16 | IPI Legacy Liquidation Co (IMPL) Delisted | Grant (A) | — | $0 | EDGAR |
| 2023-01-04 | IPI Legacy Liquidation Co (IMPL) Delisted | Mixed | +6,944 | -$13.6K | EDGAR |
| 2022-01-28 | IPI Legacy Liquidation Co (IMPL) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-10-21 | IPI Legacy Liquidation Co (IMPL) Delisted | Grant (A) | — | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.